Monkeypox and Monkey Fever: Basic Understanding for Better Community Participation in Disease Control
Biotechnology Journal International,
Page 1-12
DOI:
10.9734/bji/2022/v26i5657
Abstract
Currently, Monkeypox is a threatening viral disease terminology around the world that worries the global community after the Coronavirus pandemic. Beyond the woods of central Africa, where cases were first discovered, the geographic distribution of monkeypox cases has extended to other parts of the world including India, where cases have been imported. Under these circumstances, public confusion is noticed between Monkeypox and Monkey fever across southern parts of India. Monkeypox and Monkey fever (Kyasanur Forest Disease) are categorized as potential emerging or re-emerging Zoonotic diseases of humans and are fundamentally having clear-cut differentiation in their causative agent, clinical symptoms, and pathogenesis. Hence, it is important to clarify and eliminate the confusions which would have tremendous and dangerous public health impacts. As defined by the Global Burden of Disease Study, Emerging Infections (EIs) are those that have recently appeared in a population or previously existed but are now gaining in prevalence or geographic spread rapidly. A disease emerges from the interactions between rapidly evolving infectious agents and the environmental changes and changes in human behavior that provide these agents with favorable ecological niches. This review attempts to differentiate between the two emerging infections - Monkeypox and Monkey fever which are affecting a significant group of the population worldwide and provides a comparative picture of both diseases towards developing adequate awareness among the public and expects to complement the community-based future control measures.
Keywords:
- Zoonotic diseases
- monkeypox
- monkey fever
- emerging
- reemerging
How to Cite
Pillai, S. B., Jagannathan, S., Jeyachandran, A., Pariyapurath, N. K., Pachamuthu, R. G., Bharathi, V., Jagadibabu, S., Channappa, S. K., Premkumar, A. A., Kannaiyan, M., & Sakthivel, S. (2022). Monkeypox and Monkey Fever: Basic Understanding for Better Community Participation in Disease Control. Biotechnology Journal International, 26(5), 1-12. https://doi.org/10.9734/bji/2022/v26i5657
References
Khodakevich L, Jezek Z, Kinzanzka K. Isolation of monkeypox virus from wild squirrel infected in nature. Lancet. Jan 1986;1(8472):98-9.
DOI: 10.1016/S0140-6736(86)90748-8, PMID 2867342.
Sklenovská N, van Ranst M. Emergence of monkeypox as the most important Orthopoxvirus infection in humans. Front Public Health. 2018;6(Sep):241.
DOI: 10.3389/FPUBH.2018.00241, PMID 30234087.
Work TH, Roderiguez FR, Bhatt PN. Virological epidemiology of the 1958 epidemic of Kyasanur Forest disease. Am J Public Health Nations Health. 1959;49(7):869-74.
DOI: 10.2105/AJPH.49.7.869, PMID 13661478.
Kugelman JR, Johnston SC, Mulembakani PM, Kisalu N, Lee MS, Koroleva G, et al. Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo. Emerg Infect Dis. Feb 2014;20(2):232-9.
DOI: 10.3201/eid2002.130118, PMID 24457084.
Shah SZ, Jabbar B, Ahmed N, Rehman A, Nasir H, Nadeem S, et al. Epidemiology, pathogenesis, and control of a tick-borne disease- Kyasanur Forest disease: Current status and future directions. Front Cell Infect Microbiol. 2018;8(May):149.
DOI: 10.3389/fcimb.2018.00149, PMID 29868505.
Yadav PD, Patil S, Jadhav SM, Nyayanit DA, Kumar V, Jain S, et al. Phylogeography of Kyasanur Forest Disease virus in India (1957-2017) reveals evolution and spread in the Western Ghats region [sci rep]. Sci Rep. 2020;10(1, Dec):1966.
DOI: 10.1038/s41598-020-58242-w, PMID 32029759.
Tian D, Zheng T. Comparison and analysis of biological agent category lists based on biosafety and biodefense. PLOS ONE. 2014;9(6):101163.
DOI: 10.1371/journal.pone.0101163.t001
Muraleedharan M. Kyasanur Forest disease (KFD): Rare disease of zoonotic origin. J Nepal Health Res Counc. Sep 2016;14(34):214-8. PMID 28327690.
Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ. 1972;46(5):593-7. PMID 4340218.
di Giulio DB, Eckburg PB. Human monkeypox: An emerging zoonosis. Lancet Infect Dis. Jan 2004;4(1):15-25.
DOI: 10.1016/s1473-3099(03)00856-9, PMID 14720564.
Nichter M. Kyasanur Forest disease: an ethnography of a disease of development. Med Anthropol Q. Dec 1987;1(4):406-23.
DOI: 10.1525/maq.1987.1.4.02a00040
Urgent need for a nondiscriminatory and non-stigmatizing nomenclature for monkeypox virus – monkeypox – Virological.
[Cited Jun 22, 2022].
Available:https://virological.org/t/urgent-need-for-a-non-discriminatory-and-non-stigmatizing-nomenclature-for-monkeypox-virus/853
Wilson ME. ’Re-emerging Diseases: Overview,’ international encyclopedia of public health; Oct 2016. p. 269-77.
DOI: 10.1016/B978-0-12-803678-5.00374-X
Parker S, Nuara A, Buller RML, Schultz DA. Human monkeypox: An emerging zoonotic disease. Future Microbiol. 2007;2(1):17-34.
DOI: 10.2217/17460913.2.1.17, PMID 17661673.
ODEND’HAL S. Kyasanur Forest disease virus. The Geogr Distrib Anim Viral Dis. 1983;253-6.
DOI: 10.1016/B978-0-12-524180-9.50070-4
Monkeypox epidemiology.
[Cited Sep 24, 2022].
Available:https://www.news-medical.net/health/Monkeypox-Epidemiology.aspx
Learned LA, Reynolds MG, Wassa DW, Li Y, Olson VA, Karem K, et al. Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am J Trop Med Hyg. Aug 2005;73(2):428-34.
DOI: 10.4269/ajtmh.2005.73.428, PMID 16103616.
Simpson K, Heymann D, Brown CS, Edmunds WJ, Elsgaard J, Fine P, et al. Human monkeypox – after 40 years, an unintended consequence of smallpox eradication. Vaccine. Jul 2020;38(33): 5077-81.
DOI: 10.1016/j.vaccine.2020.04.062, PMID 32417140.
Kaler J, Hussain A, Flores G, Kheiri S, Desrosiers D. Monkeypox: A comprehensive review of transmission, pathogenesis, and manifestation. Cureus. Jul 2022;14(7):e26531.
DOI: 10.7759/cureus.26531, PMID 35928395.
Ogoina D, Izibewule JH, Ogunleye A, Ederiane E, Anebonam U, Neni A, et al. The 2017 human monkeypox outbreak in Nigeria—report of outbreak experience and response in the Niger Delta University Teaching Hospital, Bayelsa State, Nigeria. PLOS ONE. 2019;14(4):e0214229.
DOI: 10.1371/journal.pone.0214229, PMID 30995249.
Mbala PK, Huggins JW, Riu-Rovira T, Ahuka SM, Mulembakani P, Rimoin AW, et al. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of the Congo. BRIEF REPORT. J Infect Dis. 2017;216(7):824-8.
DOI: 10.1093/infdis/jix260, PMID 29029147.
okyay ra. Another epidemic in the shadow of covid 19 pandemic: A review of monkeypox. Eurasian J Oncol. 2022.
DOI: 10.14744/ejmo.2022.2022
Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, et al. Human monkeypox: Epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am. 2019;33(4):1027-43.
DOI: 10.1016/j.idc.2019.03.001, PMID 30981594.
Tarín-Vicente EJ, et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study, vol. Lancet. 2022; 400(10353):661-9.
DOI: 10.1016/S0140-6736(22)01436-2, PMID 35952705.
Holbrook MR. Kyasanur forest disease. Antiviral Res. Dec 2012;96(3):353-62.
DOI: 10.1016/j.antiviral.2012.10.005, PMID 23110991.
Rajaiah P. Kyasanur Forest Disease in India: innovative options for intervention. Hum Vaccin Immunother. 2019;15(10): 2243-8.
DOI: 10.1080/21645515.2019.1602431, PMID 30945970.
Jonsson CB, et al. Epidemiology, pathogenesis, and control of a tick-borne disease- Kyasanur Forest disease: current status and future directions. Front Cell Infect Microbiol | www. 2018;8:149.
DOI: 10.3389/fcimb.2018.00149
Lin D, Li L, Dick D, Shope RE, Feldmann H, Barrett AD, et al. Analysis of the complete genome of the tick-borne Flavivirus Omsk hemorrhagic fever virus. Virology. 2003;313(1):81-90.
DOI: 10.1016/S0042-6822(03)00246-0, PMID 12951023.
Barker WC, Mazumder R, Vasudevan S, Sagripanti JL, Wu CH. Sequence signatures in envelope protein may determine whether flaviviruses produce hemorrhagic or encephalitic syndromes. Virus Genes. 2009;39(1):1-9.
DOI: 10.1007/s11262-009-0343-4, PMID 19283462.
Sawatsky B, McAuley AJ, Holbrook MR, Bente DA. Comparative pathogenesis of Alkhumra hemorrhagic fever and Kyasanur forest disease viruses in a mouse model. PLOS Negl Trop Dis. 2014;8(6): e2934.
DOI: 10.1371/journal.pntd.0002934, PMID 24922308.
Hoff NA, Doshi RH, Colwell B, Kebela-Illunga B, Mukadi P, Mossoko M, et al. Evolution of a disease surveillance system: An increase in reporting of human monkeypox disease in the Democratic Republic of the Congo, 2001-2013. Int J Trop Dis Health. 2017;25(2):35885.
DOI: 10.9734/IJTDH/2017/35885, PMID 30123790.
Vaughan A et al. Two cases of monkeypox imported to the United Kingdom, September 2018. Eurosurveillance. 2018; 23(38).
DOI: 10.2807/1560-7917
Erez N, Achdout H, Milrot E, Schwartz Y, Wiener-Well Y, Paran N, et al. Diagnosis of imported monkey pox, Israel, 2018. Emerg Infect Dis. 2019;25(5):980-3.
DOI: 10.3201/eid2505.190076, PMID 30848724.
Pattnaik P. Kyasanur forest disease: An epidemiological view in India. Rev Med Virol. 2006;16(3):151-65.
DOI: 10.1002/rmv.495, PMID 16710839.
Mourya DT, Yadav PD. Recent scenario of emergence of Kyasanur Forest disease in India and public health importance. Curr Trop Med Rep. Mar 01, 2016;3(1): 7-13.
DOI: 10.1007/s40475-016-0067-1.
Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLOS Negl Trop Dis. 2022;16(2):e0010141.
DOI: 10.1371/journal.pntd.0010141, PMID 35148313.
Thomassen HA, Fuller T, Asefi-Najafabady S, Shiplacoff JA, Mulembakani PM, Blumberg S, et al. Pathogen-host associations and predicted range shifts of human monkeypox in response to climate change in central Africa. PLoS One. 2013; 8:e66071.
DOI: 10.1371/JOURNAL.PONE.0066071, PMID 23935820.
Weiss RA, McMichael AJ. Social and environmental risk factors in the emergence of infectious diseases. Nat Med. 2004;10(12);Suppl:S70-6.
DOI: 10.1038/nm1150, PMID 15577934.
J, SR E. & O. S. C Lederberg, editor. Emerging infections: Microbial threats to health in the United States. Washington, DC: National Academy Press; 1992.
Fauci AS. Emerging and reemerging infectious diseases: the perpetual challenge. Acad Med. 2005;80(12): 1079-85.
DOI: 10.1097/00001888-200512000-00002, PMID 16306276.
Church DL. Major factors affecting the emergence and re-emergence of infectious diseases. Clin Lab Med. 2004;24(3): 559-86.
DOI: 10.1016/j.cll.2004.05.008, PMID 15325056.
Murhekar MV, Kasabi GS, Mehendale SM, Mourya DT, Yadav PD, Tandale BVOn the transmission pattern of Kyasanur Forest disease (KFD) in India. Infect Dis Poverty. 2015;4:37.
DOI: 10.1186/s40249-015-0066-9, PMID 26286631.
CDC National Center for emerging zoonotic diseases. CDC fact sheet Page last reviewed: December 23, 2013 Content source. Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID).
[accessed: May 22, 2022] [online].
Available:https://www.cdc.gov/vhf/kyasanur/pdf/factsheet.pdf
McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis. 2014; 58(2):260-7.
DOI: 10.1093/cid/cit703, PMID 24158414.
Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, et al. Human monkeypox: Epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am. 2019;33(4):1027-43.
DOI: 10.1016/j.idc.2019.03.001, PMID 30981594.
Munivenkatappa A, Sahay RR, Yadav PD, Viswanathan R, Mourya DT S. P. D. Y. R. V. & D. T. M. Clinical & epidemiological significance of Kyasanur forest disease. Indian J Med Res. 2018;148(2): 145-50.
DOI: 10.4103/ijmr.IJMR_688_17, PMID 30381537.
Kyasanur forest disease: A public health concern.
[Cited Sep 24, 2022].
Available:https://ncdc.gov.in/WriteReadData/l892s/62082401691532083718.pdf
Laboratory testing for the monkeypox virus.
[Accessed: Oct 25, 2022] [online].
Available:https://apps.who.int/iris/bitstream/handle/10665/354488/WHO-MPX-Laboratory-2022.1-eng.pdf?sequence=1&isAllowed=y
Reynolds MG, Carroll DS, Karem KL. Factors affecting the likelihood of monkeypox’s emergence and spread in the post-smallpox era. Curr Opin Virol. 2012; 2(3):335-43.
DOI: 10.1016/J.COVIRO.2012.02.004
Oladoye MJ. Monkeypox: A neglected viral zoonotic disease. Eur J Med Educ Technol. May 2021;14(2):em2108.
DOI: 10.30935/ejmets/10911
McCollum AM, Damon IK. CTIONS Human monkeypox. Clin Infect Dis. 2014;58(2):260-7.
DOI: 10.1093/cid/cit703, PMID 24158414.
Com Sciep S, Kandi V, Pal M, Mengstie F. Epidemiology, diagnosis, and control of monkeypox disease: A comprehensive Review. Am J Infect Dis Microbiol. 2017; 5(2):94-9.
DOI: 10.12691/ajidm-5-2-4
Potter C, Warmbrod L, Vahey RA, Browett A. Factsheet: monkeypox; 2022.
[Accessed: Sep 24, 2022] [online].
Available:https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/fact_sheets/monkeypox.pdf
Kasabi GS, et al. Coverage and effectiveness of Kyasanur Forest disease (KFD) vaccine in Karnataka, South India, 2005-10. PLos Negl Trop Dis | www4January. 2013;(7)1,e2025; 7(1):e2025.
DOI: 10.1371/journal.pntd.0002025, PMID 23359421.
Munivenkatappa A, Sahay RR, Yadav PD, Viswanathan R, Mourya DT. Clinical & epidemiological significance of Kyasanur forest disease. Indian J Med Res. 2018;148(2):145-50.
DOI: 10.4103/ijmr.IJMR_688_17, PMID 30381537.
Ghosh S, Azhahianambi P, Yadav MP. Upcoming and future strategies of tick control: A review. J Vector Borne Dis. 2007;44(2):79-89. PMID 17722860.
Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox virus infection in humans across 16 countries — April-June 2022. N Engl J Med. 2022;387(8):679-91.
DOI: 10.1056/NEJMoa2207323, PMID 35866746.
Ruscio BA, Brubaker M, Glasser J, Hueston W, Hennessy TW. One Health Á a strategy for resilience in a changing arctic. Int J Circumpolar Health. 2015; 74:27913.
DOI: 10.3402/ijch.v74.27913, PMID 26333722.
One health basics | One health | CDC.
[Cited Jun 04, 2022].
Available:https://www.cdc.gov/onehealth/basics/index.html
DOI: 10.1016/S0140-6736(86)90748-8, PMID 2867342.
Sklenovská N, van Ranst M. Emergence of monkeypox as the most important Orthopoxvirus infection in humans. Front Public Health. 2018;6(Sep):241.
DOI: 10.3389/FPUBH.2018.00241, PMID 30234087.
Work TH, Roderiguez FR, Bhatt PN. Virological epidemiology of the 1958 epidemic of Kyasanur Forest disease. Am J Public Health Nations Health. 1959;49(7):869-74.
DOI: 10.2105/AJPH.49.7.869, PMID 13661478.
Kugelman JR, Johnston SC, Mulembakani PM, Kisalu N, Lee MS, Koroleva G, et al. Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo. Emerg Infect Dis. Feb 2014;20(2):232-9.
DOI: 10.3201/eid2002.130118, PMID 24457084.
Shah SZ, Jabbar B, Ahmed N, Rehman A, Nasir H, Nadeem S, et al. Epidemiology, pathogenesis, and control of a tick-borne disease- Kyasanur Forest disease: Current status and future directions. Front Cell Infect Microbiol. 2018;8(May):149.
DOI: 10.3389/fcimb.2018.00149, PMID 29868505.
Yadav PD, Patil S, Jadhav SM, Nyayanit DA, Kumar V, Jain S, et al. Phylogeography of Kyasanur Forest Disease virus in India (1957-2017) reveals evolution and spread in the Western Ghats region [sci rep]. Sci Rep. 2020;10(1, Dec):1966.
DOI: 10.1038/s41598-020-58242-w, PMID 32029759.
Tian D, Zheng T. Comparison and analysis of biological agent category lists based on biosafety and biodefense. PLOS ONE. 2014;9(6):101163.
DOI: 10.1371/journal.pone.0101163.t001
Muraleedharan M. Kyasanur Forest disease (KFD): Rare disease of zoonotic origin. J Nepal Health Res Counc. Sep 2016;14(34):214-8. PMID 28327690.
Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ. 1972;46(5):593-7. PMID 4340218.
di Giulio DB, Eckburg PB. Human monkeypox: An emerging zoonosis. Lancet Infect Dis. Jan 2004;4(1):15-25.
DOI: 10.1016/s1473-3099(03)00856-9, PMID 14720564.
Nichter M. Kyasanur Forest disease: an ethnography of a disease of development. Med Anthropol Q. Dec 1987;1(4):406-23.
DOI: 10.1525/maq.1987.1.4.02a00040
Urgent need for a nondiscriminatory and non-stigmatizing nomenclature for monkeypox virus – monkeypox – Virological.
[Cited Jun 22, 2022].
Available:https://virological.org/t/urgent-need-for-a-non-discriminatory-and-non-stigmatizing-nomenclature-for-monkeypox-virus/853
Wilson ME. ’Re-emerging Diseases: Overview,’ international encyclopedia of public health; Oct 2016. p. 269-77.
DOI: 10.1016/B978-0-12-803678-5.00374-X
Parker S, Nuara A, Buller RML, Schultz DA. Human monkeypox: An emerging zoonotic disease. Future Microbiol. 2007;2(1):17-34.
DOI: 10.2217/17460913.2.1.17, PMID 17661673.
ODEND’HAL S. Kyasanur Forest disease virus. The Geogr Distrib Anim Viral Dis. 1983;253-6.
DOI: 10.1016/B978-0-12-524180-9.50070-4
Monkeypox epidemiology.
[Cited Sep 24, 2022].
Available:https://www.news-medical.net/health/Monkeypox-Epidemiology.aspx
Learned LA, Reynolds MG, Wassa DW, Li Y, Olson VA, Karem K, et al. Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am J Trop Med Hyg. Aug 2005;73(2):428-34.
DOI: 10.4269/ajtmh.2005.73.428, PMID 16103616.
Simpson K, Heymann D, Brown CS, Edmunds WJ, Elsgaard J, Fine P, et al. Human monkeypox – after 40 years, an unintended consequence of smallpox eradication. Vaccine. Jul 2020;38(33): 5077-81.
DOI: 10.1016/j.vaccine.2020.04.062, PMID 32417140.
Kaler J, Hussain A, Flores G, Kheiri S, Desrosiers D. Monkeypox: A comprehensive review of transmission, pathogenesis, and manifestation. Cureus. Jul 2022;14(7):e26531.
DOI: 10.7759/cureus.26531, PMID 35928395.
Ogoina D, Izibewule JH, Ogunleye A, Ederiane E, Anebonam U, Neni A, et al. The 2017 human monkeypox outbreak in Nigeria—report of outbreak experience and response in the Niger Delta University Teaching Hospital, Bayelsa State, Nigeria. PLOS ONE. 2019;14(4):e0214229.
DOI: 10.1371/journal.pone.0214229, PMID 30995249.
Mbala PK, Huggins JW, Riu-Rovira T, Ahuka SM, Mulembakani P, Rimoin AW, et al. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of the Congo. BRIEF REPORT. J Infect Dis. 2017;216(7):824-8.
DOI: 10.1093/infdis/jix260, PMID 29029147.
okyay ra. Another epidemic in the shadow of covid 19 pandemic: A review of monkeypox. Eurasian J Oncol. 2022.
DOI: 10.14744/ejmo.2022.2022
Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, et al. Human monkeypox: Epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am. 2019;33(4):1027-43.
DOI: 10.1016/j.idc.2019.03.001, PMID 30981594.
Tarín-Vicente EJ, et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study, vol. Lancet. 2022; 400(10353):661-9.
DOI: 10.1016/S0140-6736(22)01436-2, PMID 35952705.
Holbrook MR. Kyasanur forest disease. Antiviral Res. Dec 2012;96(3):353-62.
DOI: 10.1016/j.antiviral.2012.10.005, PMID 23110991.
Rajaiah P. Kyasanur Forest Disease in India: innovative options for intervention. Hum Vaccin Immunother. 2019;15(10): 2243-8.
DOI: 10.1080/21645515.2019.1602431, PMID 30945970.
Jonsson CB, et al. Epidemiology, pathogenesis, and control of a tick-borne disease- Kyasanur Forest disease: current status and future directions. Front Cell Infect Microbiol | www. 2018;8:149.
DOI: 10.3389/fcimb.2018.00149
Lin D, Li L, Dick D, Shope RE, Feldmann H, Barrett AD, et al. Analysis of the complete genome of the tick-borne Flavivirus Omsk hemorrhagic fever virus. Virology. 2003;313(1):81-90.
DOI: 10.1016/S0042-6822(03)00246-0, PMID 12951023.
Barker WC, Mazumder R, Vasudevan S, Sagripanti JL, Wu CH. Sequence signatures in envelope protein may determine whether flaviviruses produce hemorrhagic or encephalitic syndromes. Virus Genes. 2009;39(1):1-9.
DOI: 10.1007/s11262-009-0343-4, PMID 19283462.
Sawatsky B, McAuley AJ, Holbrook MR, Bente DA. Comparative pathogenesis of Alkhumra hemorrhagic fever and Kyasanur forest disease viruses in a mouse model. PLOS Negl Trop Dis. 2014;8(6): e2934.
DOI: 10.1371/journal.pntd.0002934, PMID 24922308.
Hoff NA, Doshi RH, Colwell B, Kebela-Illunga B, Mukadi P, Mossoko M, et al. Evolution of a disease surveillance system: An increase in reporting of human monkeypox disease in the Democratic Republic of the Congo, 2001-2013. Int J Trop Dis Health. 2017;25(2):35885.
DOI: 10.9734/IJTDH/2017/35885, PMID 30123790.
Vaughan A et al. Two cases of monkeypox imported to the United Kingdom, September 2018. Eurosurveillance. 2018; 23(38).
DOI: 10.2807/1560-7917
Erez N, Achdout H, Milrot E, Schwartz Y, Wiener-Well Y, Paran N, et al. Diagnosis of imported monkey pox, Israel, 2018. Emerg Infect Dis. 2019;25(5):980-3.
DOI: 10.3201/eid2505.190076, PMID 30848724.
Pattnaik P. Kyasanur forest disease: An epidemiological view in India. Rev Med Virol. 2006;16(3):151-65.
DOI: 10.1002/rmv.495, PMID 16710839.
Mourya DT, Yadav PD. Recent scenario of emergence of Kyasanur Forest disease in India and public health importance. Curr Trop Med Rep. Mar 01, 2016;3(1): 7-13.
DOI: 10.1007/s40475-016-0067-1.
Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLOS Negl Trop Dis. 2022;16(2):e0010141.
DOI: 10.1371/journal.pntd.0010141, PMID 35148313.
Thomassen HA, Fuller T, Asefi-Najafabady S, Shiplacoff JA, Mulembakani PM, Blumberg S, et al. Pathogen-host associations and predicted range shifts of human monkeypox in response to climate change in central Africa. PLoS One. 2013; 8:e66071.
DOI: 10.1371/JOURNAL.PONE.0066071, PMID 23935820.
Weiss RA, McMichael AJ. Social and environmental risk factors in the emergence of infectious diseases. Nat Med. 2004;10(12);Suppl:S70-6.
DOI: 10.1038/nm1150, PMID 15577934.
J, SR E. & O. S. C Lederberg, editor. Emerging infections: Microbial threats to health in the United States. Washington, DC: National Academy Press; 1992.
Fauci AS. Emerging and reemerging infectious diseases: the perpetual challenge. Acad Med. 2005;80(12): 1079-85.
DOI: 10.1097/00001888-200512000-00002, PMID 16306276.
Church DL. Major factors affecting the emergence and re-emergence of infectious diseases. Clin Lab Med. 2004;24(3): 559-86.
DOI: 10.1016/j.cll.2004.05.008, PMID 15325056.
Murhekar MV, Kasabi GS, Mehendale SM, Mourya DT, Yadav PD, Tandale BVOn the transmission pattern of Kyasanur Forest disease (KFD) in India. Infect Dis Poverty. 2015;4:37.
DOI: 10.1186/s40249-015-0066-9, PMID 26286631.
CDC National Center for emerging zoonotic diseases. CDC fact sheet Page last reviewed: December 23, 2013 Content source. Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID).
[accessed: May 22, 2022] [online].
Available:https://www.cdc.gov/vhf/kyasanur/pdf/factsheet.pdf
McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis. 2014; 58(2):260-7.
DOI: 10.1093/cid/cit703, PMID 24158414.
Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, et al. Human monkeypox: Epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am. 2019;33(4):1027-43.
DOI: 10.1016/j.idc.2019.03.001, PMID 30981594.
Munivenkatappa A, Sahay RR, Yadav PD, Viswanathan R, Mourya DT S. P. D. Y. R. V. & D. T. M. Clinical & epidemiological significance of Kyasanur forest disease. Indian J Med Res. 2018;148(2): 145-50.
DOI: 10.4103/ijmr.IJMR_688_17, PMID 30381537.
Kyasanur forest disease: A public health concern.
[Cited Sep 24, 2022].
Available:https://ncdc.gov.in/WriteReadData/l892s/62082401691532083718.pdf
Laboratory testing for the monkeypox virus.
[Accessed: Oct 25, 2022] [online].
Available:https://apps.who.int/iris/bitstream/handle/10665/354488/WHO-MPX-Laboratory-2022.1-eng.pdf?sequence=1&isAllowed=y
Reynolds MG, Carroll DS, Karem KL. Factors affecting the likelihood of monkeypox’s emergence and spread in the post-smallpox era. Curr Opin Virol. 2012; 2(3):335-43.
DOI: 10.1016/J.COVIRO.2012.02.004
Oladoye MJ. Monkeypox: A neglected viral zoonotic disease. Eur J Med Educ Technol. May 2021;14(2):em2108.
DOI: 10.30935/ejmets/10911
McCollum AM, Damon IK. CTIONS Human monkeypox. Clin Infect Dis. 2014;58(2):260-7.
DOI: 10.1093/cid/cit703, PMID 24158414.
Com Sciep S, Kandi V, Pal M, Mengstie F. Epidemiology, diagnosis, and control of monkeypox disease: A comprehensive Review. Am J Infect Dis Microbiol. 2017; 5(2):94-9.
DOI: 10.12691/ajidm-5-2-4
Potter C, Warmbrod L, Vahey RA, Browett A. Factsheet: monkeypox; 2022.
[Accessed: Sep 24, 2022] [online].
Available:https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/fact_sheets/monkeypox.pdf
Kasabi GS, et al. Coverage and effectiveness of Kyasanur Forest disease (KFD) vaccine in Karnataka, South India, 2005-10. PLos Negl Trop Dis | www4January. 2013;(7)1,e2025; 7(1):e2025.
DOI: 10.1371/journal.pntd.0002025, PMID 23359421.
Munivenkatappa A, Sahay RR, Yadav PD, Viswanathan R, Mourya DT. Clinical & epidemiological significance of Kyasanur forest disease. Indian J Med Res. 2018;148(2):145-50.
DOI: 10.4103/ijmr.IJMR_688_17, PMID 30381537.
Ghosh S, Azhahianambi P, Yadav MP. Upcoming and future strategies of tick control: A review. J Vector Borne Dis. 2007;44(2):79-89. PMID 17722860.
Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox virus infection in humans across 16 countries — April-June 2022. N Engl J Med. 2022;387(8):679-91.
DOI: 10.1056/NEJMoa2207323, PMID 35866746.
Ruscio BA, Brubaker M, Glasser J, Hueston W, Hennessy TW. One Health Á a strategy for resilience in a changing arctic. Int J Circumpolar Health. 2015; 74:27913.
DOI: 10.3402/ijch.v74.27913, PMID 26333722.
One health basics | One health | CDC.
[Cited Jun 04, 2022].
Available:https://www.cdc.gov/onehealth/basics/index.html
-
Abstract View: 292 times
PDF Download: 73 times
Download Statistics
Downloads
Download data is not yet available.
